1. Home
  2. MNDR vs INDP Comparison

MNDR vs INDP Comparison

Compare MNDR & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNDR
  • INDP
  • Stock Information
  • Founded
  • MNDR 2016
  • INDP 2000
  • Country
  • MNDR Singapore
  • INDP United States
  • Employees
  • MNDR N/A
  • INDP N/A
  • Industry
  • MNDR
  • INDP Biotechnology: Pharmaceutical Preparations
  • Sector
  • MNDR
  • INDP Health Care
  • Exchange
  • MNDR Nasdaq
  • INDP Nasdaq
  • Market Cap
  • MNDR 6.8M
  • INDP 7.4M
  • IPO Year
  • MNDR 2024
  • INDP N/A
  • Fundamental
  • Price
  • MNDR $1.31
  • INDP $0.34
  • Analyst Decision
  • MNDR
  • INDP Strong Buy
  • Analyst Count
  • MNDR 0
  • INDP 2
  • Target Price
  • MNDR N/A
  • INDP $8.50
  • AVG Volume (30 Days)
  • MNDR 65.1K
  • INDP 760.1K
  • Earning Date
  • MNDR 06-17-2025
  • INDP 05-14-2025
  • Dividend Yield
  • MNDR N/A
  • INDP N/A
  • EPS Growth
  • MNDR N/A
  • INDP N/A
  • EPS
  • MNDR N/A
  • INDP N/A
  • Revenue
  • MNDR $13,968,535.00
  • INDP N/A
  • Revenue This Year
  • MNDR $188,831.77
  • INDP N/A
  • Revenue Next Year
  • MNDR $76.44
  • INDP N/A
  • P/E Ratio
  • MNDR N/A
  • INDP N/A
  • Revenue Growth
  • MNDR 77.38
  • INDP N/A
  • 52 Week Low
  • MNDR $1.23
  • INDP $0.31
  • 52 Week High
  • MNDR $17.36
  • INDP $2.76
  • Technical
  • Relative Strength Index (RSI)
  • MNDR N/A
  • INDP 39.35
  • Support Level
  • MNDR N/A
  • INDP $0.33
  • Resistance Level
  • MNDR N/A
  • INDP $0.37
  • Average True Range (ATR)
  • MNDR 0.00
  • INDP 0.04
  • MACD
  • MNDR 0.00
  • INDP 0.00
  • Stochastic Oscillator
  • MNDR 0.00
  • INDP 26.43

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: